Background: The 2016 cumulative incidence of Clostridioides difficile infection (CDI) in
Spain was reported by the European Center for Disease Control to be above the mean of …

Objective: To determine whether the Society for Healthcare Epidemiology of America
(SHEA) and the Infectious Diseases Society of America (IDSA) Clostridioides difficile …

Objective Clostridioides difficile infection (CDI) may pose a serious threat to
immunocompromised patients (IMC). Herein, we evaluated the clinical outcomes of IMC …

Clostridiodes difficile infection (CDI) is one of the most common hospital‐acquired infections
with high mortality rates. Optimal management of CDI depends on early recognition of …

Objectives: Clostridioides difficile infection (CDI) is the leading cause of healthcare-
associated diarrhea, often complicated by severe infection and recurrence with increased …

Context Clostridium difficile infection (CDI) produces a variety of clinical presentations
ranging from mild diarrhea to severe infection with fulminant colitis, septic shock, and death …

Background Clostridium difficile infection (CDI) severity has increased, especially among
hospitalized older adults. We evaluated clinical factors to predict mortality after CDI. Methods …

Objective: Few data are available to quantify the Clostridioides difficile infection (CDI)
burden in US adults depending on Medicaid insurance status; thus, we sought to contribute …

Background Current practice guidelines favour fidaxomicin over vancomycin and exclude
metronidazole from the recommended standard regimen for Clostridioides difficile infection …

Abstract Background Though recurrent Clostridium difficile infection (CDI) is common and
poses a major clinical concern, data are lacking regarding mortality among patients who …